Boundless Bio (BOLD) Current Leases (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Current Leases of $3.3 million for Q1 2026, up 1153.44% year-over-year from $262000.0 in Q1 2025, and up 3.69% quarter-over-quarter from $3.2 million in Q4 2025.
Boundless Bio (BOLD) Current Leases (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Current Leases for 4 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 1153.44% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (up 1153.44% YoY), while the FY2025 annual figure was $3.2 million, changed N/A from the prior year.
- Current Leases improved to $3.3 million in Q1 2026 per BOLD's latest filing, from $3.2 million in the prior quarter.
- Across five years, Current Leases topped out at $3.3 million in Q1 2026 and bottomed at $121000.0 in Q3 2024.
- Historically, Current Leases has averaged $1.8 million across 4 years, with a median of $2.0 million in 2025.
- On a YoY basis, Current Leases climbed as much as 2422.31% in 2025 and fell as far as 82.8% in 2025.
- Boundless Bio's Current Leases stood at $2.2 million in 2023, then sank by 94.49% to $121000.0 in 2024, then jumped by 2517.36% to $3.2 million in 2025, then advanced by 3.69% to $3.3 million in 2026.
- Business Quant data shows BOLD's Current Leases at $3.3 million in Q1 2026, $3.2 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Boundless Bio | 67.01 Mn | 67.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.28 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 262,000.00 |
| Sep 30, 2024 | 121,000.00 |
| Jun 30, 2024 | 837,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 2.20 Mn |